Keywords: آنتاگونیست ویتامین K; Anticoagulation; atrial fibrillation; MRCP; non-vitamin K anticoagulant oral anticoagulant; rate control; rhythm control; stroke; vitamin K antagonist;
مقالات ISI آنتاگونیست ویتامین K (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتاگونیست ویتامین K; Transcatheter aortic valve implantation; Aortic stenosis; Antithrombotic agents; Thrombosis; Bleeding; TAVI; Rétrécissement aortique; Traitements antithrombotiques; Thrombose; Saignement; AF; atrial fibrillation; DAPT; dual antiplatelet therapy; LVEF; l
Keywords: آنتاگونیست ویتامین K; CDT; Catheter Directed Thrombolysis; CT; Computed tomography; CTA; CT angiography; DOAC; direct oral anticoagulant; DUS; Doppler ultrasound; DVT; deep vein thrombosis; ECMO; Extra Corporeal Membrane Oxygenation; ICH; intracranial hemorrhage; ICU; intensiv
Keywords: آنتاگونیست ویتامین K; OAC; Oral anticoagulant; VKA; Vitamin K antagonist; DOAC; Direct oral anticoagulant; PCC; Prothrombin complex concentrate; 4F-PCC; Four factor PCC; 3F-PCC; Three factor PCC; aPCC; Activated PCC; FFP; Fresh frozen plasma; AF; Atrial fibrillation; TE; Throm
Keywords: آنتاگونیست ویتامین K; Antiphospholipid syndrome; Direct oral anticoagulants; Antiphospholipid antibodies; Recurrent thrombosis; Triple positivity; Arterial thrombosis; APS; antiphospholipid syndrome; aPL; antiphospholipid antibodies; VKA; vitamin K antagonist; DOAC; direct ora
Keywords: آنتاگونیست ویتامین K; Stroke; Thrombolysis; rt-PA; Stroke center; CED; cardioembolic disease; CT; computed tomography; DNT; door-to-needle time; ICH; intracranial hemorrhage; INR; international normalized ratio; IS; ischemic stroke; ITT; imaging-to-thrombolysis time; IV; intra
Keywords: آنتاگونیست ویتامین K; Atrial fibrillation burden; Diagnosis; Clinical outcomes; Anticoagulation; AF; atrial fibrillation; AHRE; atrial high rate episode; CI; confidence interval; CIED; cardiac implantable electronic device; CRT; cardiac resynchronization therapy; ECG; electroc
Keywords: آنتاگونیست ویتامین K; AF; atrial fibrillation; ACT; activated clotting time; aPTT; activated partial thromboplastin time; b.i.d.; twice daily; dTT; diluted thrombin time; ECT; ecarin clotting time; FFP; fresh frozen plasma; FXa; factor X activated; INR; International Normalize
Keywords: آنتاگونیست ویتامین K; FFP; Fresh Frozen Plasma; FXa; factor X activated; INR; International Normalized Ratio; NOAC; non-vitamin K antagonist oral anticoagulant; PCC; prothrombin complex concentrate; PCCa; prothrombin complex concentrate activated; RBC; red blood cells; rFVIIa;
Keywords: آنتاگونیست ویتامین K; Splanchnic vein thrombosis; Heparin; Vitamin K antagonist;
Keywords: آنتاگونیست ویتامین K; Anticoagulation; Antithrombotic; Intracranial aneurysm; Subarachnoid hemorrhage; mRS; Modified Rankin Scale; PCC; Prothrombin complex concentrate; SAH; Subarachnoid hemorrhage; SDH; Subdural hematoma; VKA; Vitamin K antagonist; WFNS; World Federation of N
Keywords: آنتاگونیست ویتامین K; aortic valve diseases; aortic valve surgery; echocardiography; indexed left atrial diameter; outcome; AVS; aortic valve surgery; BSA; body surface area; CABG; coronary artery bypass grafting; CI; confidence interval; euroSCORE; European System for Cardiac
Keywords: آنتاگونیست ویتامین K; Anticoagulation; Atrial fibrillation; Non-vitamin K antagonist oral anticoagulants; Vitamin K antagonist; Stroke;
Keywords: آنتاگونیست ویتامین K; Deep venous thrombosis; Venous thromboembolism; Anticoagulation; Novel oral anticoagulant; Vitamin K antagonist;
Keywords: آنتاگونیست ویتامین K; Transition; Adolescent; Young adult; Vitamin K antagonist; Warfarin; Coumadin; Point of care monitoring; Quality of life; Pediatrics; Warfarin self-management; Warfarin self-testing;
Keywords: آنتاگونیست ویتامین K; INR; international normalized ratio; ISI; international sensitivity index; POC; point-of-care; PT; prothrombin time; VKA; vitamin K antagonist; Point-of-care testing; International normalized ratio; Vitamin K antagonist; Oral anticoagulant; Prothrombin ti
Keywords: آنتاگونیست ویتامین K; OAT; oral anticoagulation therapy; AF; atrial fibrillation; MACE; major adverse cardiac event; INR; international normalized ratio; VKA; vitamin K antagonist; RFCA; radiofrequency catheter ablation; TTR; target therapeutic range; NOACs; new oral anticoagu
Keywords: آنتاگونیست ویتامین K; NOAC; novel oral anticoagulant; VKA; vitamin K antagonist; AF; atrial fibrillation; VTE; venous thromboembolism; aPTT; activated partial thromboplastin time; LMWH; low-molecular weight heparin; Cmax; peak concentration; Tmax; time of peak concentration; A
Keywords: آنتاگونیست ویتامین K; traumatic brain injury; delayed intracranial hemorrhage; anticoagulation therapy; coagulopathy; vitamin K antagonist;
Keywords: آنتاگونیست ویتامین K; Oral anticoagulant therapy; Thromboembolic risk; Vitamin K antagonist; Non-vitamin K antagonist oral anticoagulants; Clinical characteristics;
Keywords: آنتاگونیست ویتامین K; anticoagulation; bleeding risk; stroke prevention; AF; atrial fibrillation; b.i.d.; twice daily; CKD; chronic kidney disease; ESRD; end-stage renal disease; FDA; Food and Drug Administration; NOAC; non-vitamin K antagonist oral anticoagulant; TTR; time i
Keywords: آنتاگونیست ویتامین K; direct thrombin inhibitor; factor Xa inhibitor; hemorrhage; mortality; warfarin; AF; atrial fibrillation; AMI; acute myocardial infarction; ASMD; absolute standardized mean difference; CI; confidence interval; CKD; chronic kidney disease; GI; gastrointest
Keywords: آنتاگونیست ویتامین K; antithrombotic therapies; valve replacement; valvular heart disease; AF; atrial fibrillation; BHV; biological heart valve; CI; confidence interval; DAPT; dual antiplatelet therapy; f; factor; INR; international normalized ratio; MHV; mechanical heart valv
Keywords: آنتاگونیست ویتامین K; ablation; antiarrhythmic agents; anticoagulation; atrial fibrillation; non-vitamin K antagonist oral anticoagulant; vitamin K antagonist;
Keywords: آنتاگونیست ویتامین K; IPD; individual patient data; NOAC; novel oral anticoagulant; VKA; vitamin K antagonist;
Keywords: آنتاگونیست ویتامین K; TKA; total knee arthroplasty; VTE; venous thromboembolism; ACCP; American College of Chest Physicians; AAOS; American Academy of Orthopaedic Surgeons; DVT; deep vein thrombosis; PE; pulmonary embolism; VKA; vitamin K antagonist; INR; International Normali
Keywords: آنتاگونیست ویتامین K; Venous thromboembolism; Heparin; Vitamin K antagonist; Bleeding; Portal hypertension
Keywords: آنتاگونیست ویتامین K; AF; atrial fibrillation; APT; antiplatelet therapy; BARC; Bleeding Academic Research Consortium; CHA2DS2-VASc; congestive heart failure, hypertension, age ⥠75 years (doubled), diabetes, stroke (doubled), vascular disease, age 65 to 74 years, sex catego
Keywords: آنتاگونیست ویتامین K; atrial fibrillation; cusp; Doppler gradient; valvular heart disease; vitamin K antagonist; AF; atrial fibrillation; BPV; bioprosthetic valve; BPVT; bioprosthetic valve thrombosis; INR; international normalized ratio; TEE; transesophageal echocardiogram; T
Keywords: آنتاگونیست ویتامین K; oral anticoagulant; warfarin; vitamin K antagonist; pharmacogenomics; algorithm
Keywords: آنتاگونیست ویتامین K; AF; atrial fibrillation; DC; direct current; NOAC; non-vitamin K antagonist oral anticoagulant; SAMe-TT2R2; sex female, age < 60 years, medical history (more than two comorbidities), treatment (interacting drugs, eg, amiodarone for rhythm control), tobacc
Keywords: آنتاگونیست ویتامین K; BISTRO; Boehringer Ingelheim Studyin Thrombosis; LDUH; low-dose unfractionated heparin; LMWH; low-molecular-weight heparin; NOAC; non-vitamin K antagonist oral anticoagulant; OD; once daily; VKA; vitamin K antagonist;
Keywords: آنتاگونیست ویتامین K; Anti-FXa; anti-activated factor X (activity); aPTT; activated partial thromboplastin time; CTAD; citrate, theophylline, adenosine, dipyridamole; CV; coefficient of variation; ELISA; enzyme-linked immunosorbent assay; FV; (coagulation) factor V; INR; inter
Keywords: آنتاگونیست ویتامین K; Atrial fibrillation; non-warfarin oral anticoagulant (NOAC); stroke; thromboembolism; vitamin K antagonist
Keywords: آنتاگونیست ویتامین K; CI; confidence interval; DVT; deep vein thrombosis; FDA; Food and Drug Administration; LMWH; low-molecular weight heparin; NOAC; New oral anticoagulant; PE; pulmonary embolism; RR; relative risk; UFH; unfractionated heparin; VKA; vitamin K antagonist; VTE
Keywords: آنتاگونیست ویتامین K; AF; atrial fibrillation; ARR; absolute risk reduction; ASA; aspirin (acetylsalicylic acid); GP; general practitioner; ICH; intracranial hemorrhage; IE; ischemic event; INR; international normalized ratio; LMWH; low-molecular-weight heparin; NACs; Network
Keywords: آنتاگونیست ویتامین K; VTE; venous thromboembolism; VKA; vitamin K antagonist; TTR; time in therapeutic range; PINRR; proportion of INR measurements in range; INR; international normalized ratio; CI; confidence interval; UK; United Kingdom; RCT; randomized controlled trial; ICH
Keywords: آنتاگونیست ویتامین K; ACS; acute coronary syndrome; AF; atrial fibrillation; NOAC; new oral anticoagulant; PE; pulmonary embolism; RCT; randomized controlled trial; RR; risk ratio; VKA; vitamin K antagonist; VTE; venous thromboembolism;
Keywords: آنتاگونیست ویتامین K; AF; atrial fibrillation; ATRIA; Anticoagulation and Risk Factors in Atrial Fibrillation; CHADS2; congestive heart failure, hypertension, age ⥠75 years, diabetes, prior stroke or transient ischemic attack; CHA2DS2-VASc; congestive heart failure, hyperte
Keywords: آنتاگونیست ویتامین K; AF; atrial fibrillation; cW; continuous warfarin; dOAC; discontinued warfarin; LA; left atrium; NOAC; new oral anticoagulants; OAC; oral anticoagulation; RF; radiofrequency; VKA; vitamin K antagonists; Atrial fibrillation; Catheter ablation; Heparin; Oral
Keywords: آنتاگونیست ویتامین K; THA; total hip arthroplasty; VTE; venous thromboembolism; DVT; deep vein thrombosis; PE; pulmonary embolism; LMWH; low-molecular-weight heparin; VKA; vitamin K antagonist; AAOS; American Academy of Orthopaedic Surgeons; ACCP; American College of Chest Phy
Keywords: آنتاگونیست ویتامین K; ACP; Amplatzer Cardiac Plug; AF; atrial fibrillation; ASA; aspirin; DPI; dual platelet inhibition; LA; left atrium/atrial; LAA; left atrial appendage; NVAF; nonvalvular atrial fibrillation; OAC; oral anticoagulation; PROTECT-AF; Percutaneous Closure of th
Comparative Effectiveness and Safety of Apixaban and Vitamin K Antagonist Therapy in Patients With Nonvalvular Atrial Fibrillation Treated in Routine German Practice
Keywords: آنتاگونیست ویتامین K; Anticoagulant; Vitamin k antagonist; Apixaban; Non-valvular atrial fibrillation; Stroke;
Ulcères nécrotiques sous antivitamine K, sans déficit en protéine C et S associé
Keywords: آنتاگونیست ویتامین K; Ulcère; Antivitamine K; Nécrose; Leg ulcer; Vitamin K antagonist; Necrosis;
Bleeding and asymptomatic overdose in patients under Vitamin K antagonist therapy: Frequency and risk factors
Keywords: آنتاگونیست ویتامین K; Vitamin K antagonist; Bleeding; Risk factor; Overdose;
Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis
Keywords: آنتاگونیست ویتامین K; AF; atrial fibrillation; CI; confidence interval; DCCV; direct current cardioversion; NOAC; non-vitamin K antagonist oral anticoagulant; OR; odds ratio; TEE; transesophageal echocardiography; TIA; transient ischemic attack; RCT; randomized controlled tria
Thrombin generation test: A reliable tool to evaluate the pharmacodynamics of vitamin K antagonist rodenticides in rats
Keywords: آنتاگونیست ویتامین K; CAT; calibrated automated test; ETP; endogenous thrombin potential; F; factor; LT; lag time; PD; pharmacodynamics; PH; peak height; PNrP; pooled normal rat plasma; PPP; platelet poor plasma; PT; prothrombin time; TGT; thrombin generation test; TTP; time t
Coagulation Factor Plasma Levels Following Administration of a 4-Factor Prothrombin Complex Concentrate for Rapid Vitamin K Antagonist Reversal in Japanese Patients
Keywords: آنتاگونیست ویتامین K; Coagulation factor; Hemorrhage; Prothrombin complex concentrate; Surgery; Vitamin K antagonist;
The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: A nationwide cohort study in Taiwan
Keywords: آنتاگونیست ویتامین K; AF; atrial fibrillation; AKI; acute kidney injury; CHA2DS2-VASc; congestive heart failure, hypertension, aged 75â¯years or older, diabetes mellitus, previous stroke/transient ischemic attack, vascular disease, aged 65 to 74â¯years, female; CKD; chronic
Quel bilan à deux ans de la mise en place de l'accompagnement des patients traités par anti-vitamines K ? Le point de vue du pharmacien d'officine
Keywords: آنتاگونیست ویتامین K; Pharmacie d'officine; Entretien pharmaceutique; Anti-vitamines K; Community pharmacy; Pharmaceutical care program; Vitamin k antagonist;